HTRA1 and infection: With the increasing number of infections produced by H. parasuis and increasing antibiotic resistance among bacterial pathogens, we propose that pharmacological inhibition with the tonB-dependent siderophore receptor, KdsA and HtrA, as new therapeutic targets can be an effective alternative strategy for the clinical treatment of H. parasuis.